At Scientific American, Beth Mole has a longer story about the FDA’s recent decision to exert more control over the use of fecal transplants — procedures that attempt to cure disorders related to gut bacteria by, essentially, giving you somebody else’s gut bacteria. We already talked briefly about this decision, which has some benefits and some detriments. This new piece gets more in-depth.